Spots Global Cancer Trial Database for undifferentiated leukemia

Every month we try and update this database with for undifferentiated leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	NCT05316701	Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related...	Orca-T Standard-of-Car...	18 Years - 65 Years	Orca Biosystems, Inc.
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies	NCT02991898	Acute Lymphobla... Burkitt Lymphom... Natural Killer ... Chronic Myeloge... Myelodysplastic... Large-cell Lymp... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Hodgkin Lymphom... Multiple Myelom... Acute Myelogeno... Biphenotypic Le... Undifferentiate...	Infusion of Tre...	18 Years - 75 Years	Masonic Cancer Center, University of Minnesota
Intraosseous Infusion of Unrelated Cord Blood Grafts	NCT00967525	Acute Myeloid L... Acute Lymphobla... Chronic Myeloge... Myelodysplastic...	cord blood infu...	36 Months - 60 Years	Emory University
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	NCT05316701	Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related...	Orca-T Standard-of-Car...	18 Years - 65 Years	Orca Biosystems, Inc.
Intraosseous Infusion of Unrelated Cord Blood Grafts	NCT00967525	Acute Myeloid L... Acute Lymphobla... Chronic Myeloge... Myelodysplastic...	cord blood infu...	36 Months - 60 Years	Emory University
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	NCT01012492	AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ...	Abatacept	12 Years -	Boston Children's Hospital
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	NCT01012492	AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ...	Abatacept	12 Years -	Boston Children's Hospital
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	NCT05316701	Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Undifferentiate... Myelodysplastic... Acute Leukemia Therapy-Related...	Orca-T Standard-of-Car...	18 Years - 65 Years	Orca Biosystems, Inc.
Allo HSCT Using RIC and PTCy for Hematological Diseases	NCT05805605	Acute Myelogeno... Acute Lymphocyt... Biphenotypic Ac... Undifferentiate... Prolymphocytic ... Chronic Myeloge... Plasma Cell Leu... Myelodysplastic... Leukemia, Myelo... Myelodysplastic... Burkitt Lymphom... Relapsed T-Cell... Relapsed Chroni... Small Lymphocyt... Marginal Zone L... Follicular Lymp... Myeloproliferat... Myelofibrosis	Peripheral Bloo... Allopurinol 300... Fludarabine Cyclophosphamid... Bone Marrow Cel... Total Body Irra... Sirolimus Pill Mycophenolate M...	- 75 Years	Masonic Cancer Center, University of Minnesota

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: